Olema Pharmaceuticals, Inc. · NASDAQ:OLMA
Paradigm Biocapital Advisors LP reported a 9.99% stake in Olema Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP reported a 9.99% stake in Olema Pharmaceuticals, Inc., 7,429,355 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 7,429,355
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 9.99% | 7,429,355 |
| Paradigm BioCapital Advisors GP LLC | 9.99% | 7,429,355 |
| Senai Asefaw, M.D. | 9.99% | 7,429,355 |
| Paradigm BioCapital International Fund Ltd. | 9.10% | 6,777,072 |
Source
Related
- Olema Pharmaceuticals, Inc.
- Paradigm Biocapital Advisors LP
- Olema Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Bvf Partners L P · Oct 16, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Harmon Cyrus · Jul 27, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2026